The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women

Overview

This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: February 2011

Detailed Description

This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled. They will take the evaluation of spine X-ray and answer to a few questions. Their medical record will be reviewed and relevant clinical findings will be collected.

Interventions

  • Other: Fracture evaluation
    • DEXA(Dual-energy X-ray absorptiometry), X-ray

Arms, Groups and Cohorts

  • Post menopausal women
    • Post menopausal women between 50 to 80

Clinical Trial Outcome Measures

Primary Measures

  • The prevalence of OVCFs confirmed by history and X-ray
    • Time Frame: 1 day

Secondary Measures

  • The prevalence of asymptomatic (or missed) fractures
    • Time Frame: 1 day

Participating in This Clinical Trial

Inclusion Criteria

  • Subjects who were diagnosed post menopausal state – Subjects over 50 years old – The Definition of Post Menopause Women : Women whose last menstruation was over 12months ago – Subjects who visit orthopedic surgery – Subjects who have informed consents Exclusion Criteria:

  • Subjects who are not confirmed as post menopause state – Subjects who do not understand the contents of questionnaire – Subjects over 80 years old – Subjects experienced any high energy fracture (including trash and fall) within 3 months. – Subjects experienced a fracture except vertebral fracture within 6 months – Unable to evaluate L-spine BMD over 2 levels because of spinal fracture or instrumentation for L-spine 1-4. – Unable to evaluate BMD at both femur because of hip fracture or instrumentation.

Gender Eligibility: Female

Minimum Age: 50 Years

Maximum Age: 79 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • GlaxoSmithKline
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • GSK Clinical Trials, Study Director, GlaxoSmithKline

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.